Cargando…
L-GSH Supplementation in Conjunction With Rifampicin Augments the Treatment Response to Mycobacterium tuberculosis in a Diabetic Mouse Model
Both active tuberculosis (TB) and asymptomatic latent Mycobacterium tuberculosis (M. tb) infection (LTBI) cause significant health burdens to humans worldwide. Individuals with immunocompromising health conditions, such as Type 2 Diabetes Mellitus (T2DM), have a weakened ability to control M. tb inf...
Autores principales: | Beever, Abrianna, Kachour, Nala, Owens, James, Sasaninia, Kayvan, Kolloli, Afsal, Kumar, Ranjeet, Ramasamy, Santhamani, Sisliyan, Christina, Khamas, Wael, Subbian, Selvakumar, Venketaraman, Vishwanath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263396/ https://www.ncbi.nlm.nih.gov/pubmed/35814213 http://dx.doi.org/10.3389/fphar.2022.879729 |
Ejemplares similares
-
Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection
por: Cao, Ruoqiong, et al.
Publicado: (2021) -
Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs
por: Kachour, Nala, et al.
Publicado: (2022) -
Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection
por: Cao, Ruoqiong, et al.
Publicado: (2021) -
Additive Effects of Cyclic Peptide [R4W4] When Added Alongside Azithromycin and Rifampicin against Mycobacterium avium Infection
por: Kelley, Melissa, et al.
Publicado: (2023) -
A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection
por: Kolloli, Afsal, et al.
Publicado: (2023)